Genetic Testing Services
Hereditary cancer, cardiovascular & longevity panels.
Our flagship panel covers more than 200 genes implicated in hereditary cancers (BRCA1/2, Lynch syndrome, hereditary diffuse gastric cancer), familial cardiovascular disease (FH, hypertrophic cardiomyopathy, long QT), and longevity-relevant markers (APOE, FOXO3, klotho). Methylation-based epigenetic age and telomere length round out the report.
Right drug, right dose, the first time.
PGx testing identifies CYP450 variants that affect how you metabolise common medications: anticoagulants, SSRIs, statins, opioids, and oncology drugs. We integrate results into your medical record so future prescriptions are calibrated to your genome.
- 01
200+ genes
Hereditary cancer, cardiovascular, neurological, metabolic.
- 02
PGx profiling
Drug-gene interactions for 80+ commonly prescribed drugs.
- 03
Epigenetic age
Horvath / GrimAge methylation clocks, telomere length.
- 04
Bilingual report
Plain-language summary in English or 中文 plus physician consult.
- 05
Family planning
Reproductive carrier screen for 280+ recessive conditions.
- 06
Mayo Clinic protocols
Variant interpretation aligned with ACMG and Mayo standards.
Frequently Asked
How is the sample collected?
A simple buccal swab or saliva tube. No blood draw required for the core panel; whole-genome sequencing requires a small EDTA blood sample.
How long do results take?
Standard reports return in 4–6 weeks. Pharmacogenomics in 2 weeks. Methylation age in 6–8 weeks.
Is my genetic data kept private?
Yes. Samples are processed in CAP/CLIA-accredited labs under PIPEDA. Data is never sold or shared without your written consent.
Do you offer counselling?
Every report includes a 45-minute physician consultation; complex findings are referred to a certified genetic counsellor.